Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
THC Stock Forecast 2026-2027
$194.91
Current Price
$16.79B
Market Cap
Buy 20
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to THC Price Targets
+47.8%
To High Target of $288.00
+25.7%
To Median Target of $245.00
+7.7%
To Low Target of $210.00
THC Price Momentum
-4.6%
1 Week Change
+12.9%
1 Month Change
+11.3%
1 Year Change
-1.9%
Year-to-Date Change
-21.2%
From 52W High of $247.21
+33.0%
From 52W Low of $146.60
📊 TOP ANALYST CALLS
Did THC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Tenet Healthcare is one of their latest high-conviction picks.
Latest THC Stock Price Targets & Analyst Predictions
Based on our analysis of 5 Wall Street analysts, THC has a bullish consensus with a median price target of $245.00 (ranging from $210.00 to $288.00). The overall analyst rating is Strong Buy (9.1/10). Currently trading at $194.91, the median forecast implies a 25.7% upside. This outlook is supported by 20 Buy, 2 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
THC Analyst Ratings
20
Buy
2
Hold
0
Sell
THC Price Target Range
Low
$210.00
Average
$245.00
High
$288.00
Current: $194.91
Latest THC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for THC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 13, 2026 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $231.00 |
| Jul 9, 2026 | Barclays | Andrew Mok | Overweight | Maintains | $240.00 |
| Jun 22, 2026 | TD Cowen | Buy | Maintains | $N/A | |
| May 5, 2026 | Barclays | Overweight | Maintains | $N/A | |
| May 5, 2026 | Baird | Neutral | Maintains | $N/A | |
| May 4, 2026 | Stephens & Co. | Overweight | Maintains | $N/A | |
| May 1, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| May 1, 2026 | Guggenheim | Buy | Maintains | $N/A | |
| May 1, 2026 | Wells Fargo | Overweight | Maintains | $N/A | |
| May 1, 2026 | Keybanc | Overweight | Maintains | $N/A | |
| Mar 12, 2026 | Guggenheim | Buy | Maintains | $N/A | |
| Mar 12, 2026 | Mizuho | Outperform | Maintains | $N/A | |
| Feb 20, 2026 | Leerink Partners | Outperform | Maintains | $N/A | |
| Feb 17, 2026 | Truist Securities | Buy | Maintains | $N/A | |
| Feb 13, 2026 | Barclays | Overweight | Maintains | $N/A | |
| Feb 13, 2026 | Guggenheim | Buy | Maintains | $N/A | |
| Feb 12, 2026 | Jefferies | Buy | Maintains | $N/A | |
| Feb 12, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| Feb 12, 2026 | UBS | Buy | Maintains | $N/A | |
| Feb 12, 2026 | Keybanc | Overweight | Maintains | $N/A |
Tenet Healthcare Corporation (THC) Competitors
The following stocks are similar to Tenet Healthcare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
THC
Tenet Healthcare
mkt cap
17.59B
Tenet Healthcare Corporation (THC) Financial Data
Tenet Healthcare Corporation has a market capitalization of $16.79B with a P/E ratio of 10.4x. The company generates $21.45B in trailing twelve-month revenue with a 7.9% profit margin.
Revenue growth is +2.8% quarter-over-quarter, while maintaining an operating margin of +17.9% and return on equity of +30.3%.
Valuation Metrics
Market Cap
$16.79B
Enterprise Value
$30.85B
P/E Ratio
10.4x
PEG Ratio
0.1x
Price/Sales
0.8x
Growth & Margins
Revenue Growth (YoY)
+2.8%
Gross Margin
+83.4%
Operating Margin
+17.9%
Net Margin
+7.9%
EPS Growth
+72.9%
Financial Health
Cash/Price Ratio
+17.7%
Current Ratio
1.4x
Debt/Equity
149.3x
ROE
+30.3%
ROA
+7.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Tenet Healthcare Corporation (THC) Business Model
About Tenet Healthcare Corporation
What They Do
Provides diversified healthcare services across the U.S.
Business Model
Tenet Healthcare generates revenue through its extensive network of acute care and specialty hospitals, ambulatory surgery centers, and outpatient facilities. Its business model integrates clinical care across various settings and includes managing a large ambulatory surgery platform that focuses on elective procedures, allowing for efficient service delivery and patient care.
Additional Information
With a strong presence in the healthcare market, Tenet Healthcare also supports a network of employed physicians and enhances operational efficiency through centralized services in the Philippines. The company's ability to deliver a wide range of medical and surgical services positions it as a significant player in the U.S. healthcare landscape.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
77,000
CEO
Dr. Saumya Sutaria M.D.
Country
United States
IPO Year
1982
Website
www.tenethealth.comTenet Healthcare Corporation (THC) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Tenet Healthcare (THC) Falls More Steeply Than Broader Market: What Investors Need to Know
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $194.91, denoting a -2.15% move from the preceding trading day.
Jul 17, 2026
By Zacks Equity Research
Tale of the Tape
Tenet Healthcare (THC) Stock Sinks As Market Gains: Here's Why
Tenet Healthcare (THC) closed the most recent trading day at $204.25, moving 1.22% from the previous trading session.
Jul 10, 2026
By Zacks Equity Research
Tale of the Tape
Brookdale Senior Q2'26 Sneak Peek: Occupancy Volume Rises to 82.4%
BKD's Q2 weighted average occupancy rises to 82.4% as steady resident demand and RevPAR growth expectations set the stage for its upcoming earnings.
Jul 10, 2026
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
Zacks Style Scores help investors identify top-rated stocks tailored to their investment style, providing a useful tool for stock selection.
Why It Matters
Zacks Style Scores can help identify high-potential stocks tailored to specific investing strategies, enhancing portfolio performance and decision-making.
Source: Zacks Investment Research
Market Sentiment:
Positive
Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It
9 days ago
Quick Summary
Tenet (THC) has gained significant attention from Zacks.com users, highlighting the importance of understanding factors that may influence the stock's performance.
Why It Matters
Increased attention from Zacks.com users could indicate rising interest or sentiment around Tenet (THC), potentially influencing stock price and trading volume.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Tenet Healthcare (THC) closed at $204.25, reflecting a 1.22% increase from the previous trading day.
Why It Matters
Tenet Healthcare's stock movement indicates market sentiment and potential volatility, impacting investor decisions on buying or selling shares.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
U.S.-Iran tensions may increase demand for defensive investments, highlighting Tenet Healthcare, Elevance Health, and Aveanna Healthcare as undervalued medical stocks.
Why It Matters
Rising U.S.-Iran tensions may drive investors toward defensive stocks, indicating potential gains for Tenet Healthcare, Elevance Health, and Aveanna Healthcare amid market uncertainty.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Zacks emphasizes its Rank system based on earnings estimates and revisions to identify strong stocks, while also monitoring value, growth, and momentum trends for investment opportunities.
Why It Matters
The emphasis on earnings estimates and revisions highlights potential stock performance, guiding investors toward high-potential stocks amid current market trends.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Zacks Style Scores help investors identify top-rated stocks aligned with their investment style, providing a valuable tool for stock selection.
Why It Matters
Zacks Style Scores provide a streamlined method for identifying high-potential stocks, enhancing investment strategies and decision-making for better portfolio performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About THC Stock
What is Tenet Healthcare Corporation's (THC) stock forecast for 2027?
Based on our analysis of 5 Wall Street analysts, Tenet Healthcare Corporation (THC) has a median price target of $245.00. The highest price target is $288.00 and the lowest is $210.00.
Is THC stock a good investment in 2027?
According to current analyst ratings, THC has 20 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $194.91. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for THC stock?
Wall Street analysts predict THC stock could reach $245.00 in the next 12 months. This represents a 25.7% increase from the current price of $194.91. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Tenet Healthcare Corporation's business model?
Tenet Healthcare generates revenue through its extensive network of acute care and specialty hospitals, ambulatory surgery centers, and outpatient facilities. Its business model integrates clinical care across various settings and includes managing a large ambulatory surgery platform that focuses on elective procedures, allowing for efficient service delivery and patient care.
What is the highest forecasted price for THC Tenet Healthcare Corporation?
The highest price target for THC is $288.00 from at , which represents a 47.8% increase from the current price of $194.91.
What is the lowest forecasted price for THC Tenet Healthcare Corporation?
The lowest price target for THC is $210.00 from at , which represents a 7.7% increase from the current price of $194.91.
What is the overall THC consensus from analysts for Tenet Healthcare Corporation?
The overall analyst consensus for THC is bullish. Out of 5 Wall Street analysts, 20 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $245.00.
How accurate are THC stock price projections?
Stock price projections, including those for Tenet Healthcare Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 18, 2026 7:23 AM UTC